Professor Savita Rangarajan

Publications

94 publications

Page 5 of 10

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

P. Collins, E. Chalmers, P. Chowdary, D. Keeling, M. Mathias, J. O'donnell, K. J. Pasi, S. Rangarajan & A. Thomas, 2016, Haemophilia, 22(4), 487-498

DOI: 10.1111/hae.13013

Type: article

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

T. Lissitchkov, K. Hampton, M. Von Depka, C. Hay, S. Rangarajan, E. Tuddenham, K. Holstein, A. Huth-kühne, I. Pabinger, S. Knaub, J. Bichler & J. Oldenburg, 2016, Haemophilia, 22(2), 225-231

DOI: 10.1111/hae.12793

Type: article

Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

V. Jiménez-Yuste, J. Oldenburg, S. Rangarajan, M. H Kurth, J. Bozzo & E. Santagostino, 2016, Haemophilia, 22(1), e71-e74

DOI: 10.1111/hae.12857

Type: article

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

B. Nolan, J. Mahlangu, D. Perry, G. Young, R. Liesner, B. Konkle, S. Rangarajan, S. Brown, H. Hanabusa, K. J. Pasi, I. Pabinger, S. Jackson, L. M. Cristiano, X. Li, G. F. Pierce & G. Allen, 2016, Haemophilia, 22(1), 72-80

DOI: 10.1111/hae.12766

Type: article

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

Johnny Mahlangu, Margaret Ragni, Naresh Gupta, Savita Rangarajan, Robert Klamroth, Johannes Oldenburg, Keiji Nogami, Guy Young, Lynda Cristiano, Yingwen Dong, Geoffrey Allen, Glenn Pierce & Brian Robinson, 2016, Thrombosis and Haemostasis, 116(07), 1-8

DOI: 10.1160/TH15-10-0780

Type: article

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

Paul Batty, Gary W Moore, Sean Platton, James C Maloney, Ben Palmer, Louise Bowles, K John Pasi, Savita Rangarajan & Daniel P Hart, 2015, Thrombosis and Haemostasis, 114(4), 804-811

DOI: 10.1160/TH14-12-1062

Type: article

Inhibitors in nonsevere haemophilia A

Alice S van Velzen, Corien L Eckhardt, Daniel P Hart, Marjolein Peters, Savita Rangarajan, Maria Elisa Mancuso, Frans J Smiers, Kate Khair, Pia Petrini, Victor Jiménez-Yuste, Charles R M Hay, Johanna G van der Bom, Thynn T Yee & Karin Fijnvandraat, 2015, Thrombosis and Haemostasis, 114(1), 46-55

DOI: 10.1160/TH14-11-0940

Type: article

[Accepted Abstracts: 2015 Scientific Symposium of the Hemostasis and Thrombosis Research Society April 16-18, 2015 New Orleans, Louisiana] Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency

Savita Rangarajan, M. Karimi, B. Schwartz, Sigurd Knaub & Flora Peyvandi, 2015, Haemophilia, 21(3), e271-e272

Type: conference

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison

C. R. M. Hay, B. P. Palmer, E. A. Chalmers, D. P. Hart, R. Liesner, S. Rangarajan, K. Talks, M. Williams & P. W. Collins, 2015, Haemophilia, 21(2), 219-226

DOI: 10.1111/hae.12563

Type: article

[Poster Presentations] Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

J. Pasi, D. Perry, J. Mahlangu, B. Konkle, S. Rangarajan, S.A. Brown, H. Hanabusa, S. Jackson, I. Pabinger, L. M. Cristiano, X. Li, G.F. Pierce & G. Allen, 2015, Haemophilia, 21(S2), 52-53

Type: conference

Biography

Professor Savita Rangarajan is an internationally renowned Haematologist with over two decades of experience at the consultant level, specialising in coagulation medicine and haemophilia. She is currently serving as Professor of Clinical Haematology at the University of Southampton.

Trained in India at Mumbai University, where she earned her MBBS and MD, Savita furthered her medical education and clinical training in the United Kingdom. She holds fellowships from both the Royal College of Physicians and the Royal College of Pathologists and is listed on the UK’s Specialist Register as a Haematologist.

Her clinical career has spanned major UK institutions including Guy’s and St Thomas’ Hospital and Hampshire Hospitals NHS Foundation Trust, where she developed and led comprehensive haemostasis and thrombosis services. She played a pivotal role in establishing the Southern Haemophilia Network and integrating cutting-edge clinical trials platforms across multiple NHS trusts.

Savita has been instrumental in advancing gene and cell therapy for bleeding disorders, leading major international Phase III clinical trials and contributing to landmark publications in journals such as The New England Journal of Medicine, Nature Medicine, and The Lancet. She has secured over £1 million in investigator-initiated research grants and is actively engaged in translational research, particularly in thrombosis and haemophilia care.

In addition to her work in the UK, she is a Consultant to Reliance Life Sciences in India and leads their Gene and Cell Therapy initiatives. She has also established a Clinical Trials and Research Unit at KJ Somaiya Super Speciality Hospital in Mumbai, reflecting her commitment to global health and cross-border collaboration.

Savita is co-founder of the Southern Interdisciplinary Global Health Network (SigHN) and founder of the Scientific Academic Coagulation Consortium (SACC), both of which foster collaborative international research. She is a member of numerous professional societies, including the UK Haemophilia Doctors Organisation, American Society of Hematology, International Society of Thrombosis and Haemostasis, and the American Society of Gene & Cell Therapy.

Connect with Savita

Publications

Biography